ASTCT is dedicated to advancing the field of hematopoietic cell transplantation and cellular therapy through groundbreaking research, high-quality education, impactful advocacy and clinical excellence.
About ASTCT
Access resources to advance your career, discounts on meetings and opportunities to collaborate with colleagues. For a limited time, join ASTCT through Sept. 30, 2026, to access benefits through Dec. 31, 2027.
Join ASTCT
ASTCT Talks features industry leaders coming together to tackle important subjects in the growing field of transplantation and cellular therapy. You can listen to ASTCT Talks on the following platforms: Spotify, Google Podcasts and Apple Podcasts.
Listen Here
Now Available! Access the latest issue of Transplantation and Cellular Therapy
Read the Journal
Through expert-led sessions and collaborative discussions, attendees will examine immune-reset therapies in autoimmune disease through the lenses of clinical decision-making, durability, and long-term responsibility, while fostering cross-disciplinary dialogue among neurology, rheumatology, transplant and cellular therapy stakeholders.
As the first installment in the 2026 Johnson&Johnson and Legend CAR T Series, join Dr. Joy Ho and Dr. Marco Davila as they explore the latest advances in in vivo CAR T cell therapy, offering insights from both clinical and translational research perspectives.
Sponsored by Johnson and Johnson and Legend Biotech.
TP53 mutated MDS and AML represent some of the most difficult diseases to treat, with poor prognosis. This webinar uses a case based approach to debate the best transplant approach (including no transplant) for older patients with TP53 mutated disease in different scenarios.
More Meetings
Review the Guideline
View More
Browse all Education